Home » Newsletters » BioWorld Asia

BioWorld Asia

Oct. 13, 1999

View Archived Issues

New European Commission Structure Leaves Questions

U.S. FDA Gives First-Ever Approval To Proneuron For Spinal Cord Cell Therapy Test

UK Researchers Show Drug Reduces Tumor Blood Flow

Trials Begin For Bayer's 1st German Biotech Product

Chemunex Launches New Test For E. Coli In Drinking Water

Focus On New Peptide Could Herald Lifetime Flu Vaccine

NicOx Launches $34M IPO To Speed Up Its R&D Efforts

MediGene In-Licenses Its Phase II-Ready CHF Drug

Alchemia To Build Pilot Plant For Carbohydrate Production

Genetically Modified Tomato Gets 'Amber Light' From EU

Other News To Note

European Biotech Community Denounces

Inpharmatica Unveils Database On Structure-Function Relationships

VitaResc Extends Product Pipeline With SIRS Drug

Genset Finds Schizophrenia Gene Through Janssen Collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...